Sodium MR Neuroimaging

References

1. 1.↵
   1. Noda M,
   2. Hiyama TY

   . Sodium sensing in the brain. Pflugers Arch 2015;467:465–74 doi:10.1007/s00424-014-1662-4 pmid:25491503

   CrossRefPubMed
2. 2.↵
   1. Hernandez CM,
   2. Richards JR

   . Physiology, Sodium Channels. StatPearls Publishing; 2021
3. 3.↵
   1. Joseph D,
   2. Pidathala S,
   3. Mallela AK, et al

   . Structure and gating dynamics of Na(+)/Cl(-) coupled neurotransmitter transporters. Front Mol Biosci 2019;6:80 doi:10.3389/fmolb.2019.00080 pmid:31555663

   CrossRefPubMed
4. 4.↵
   1. Dekker LJM,
   2. Wu S,
   3. Jurriens C, et al

   . Metabolic changes related to the IDH1 mutation in gliomas preserve TCA-cycle activity: an investigation at the protein level. FASEB J 2020;34:3646–57 doi:10.1096/fj.201902352R pmid:31960518

   CrossRefPubMed
5. 5.↵
   1. Lo WD,
   2. Betz AL,
   3. Schielke GP, et al

   . Transport of sodium from blood to brain in ischemic brain edema. Stroke 1987;18:150–57 doi:10.1161/01.str.18.1.150 pmid:3810748

   Abstract/FREE Full Text
6. 6.↵
   1. Kaplan DI,
   2. Isom LL,
   3. Petrou S

   . Role of sodium channels in epilepsy. Cold Spring Harb Perspect Med 2016;6:a022814 doi:10.1101/cshperspect.a022814 pmid:27143702

   Abstract/FREE Full Text
7. 7.↵
   1. Madelin G,
   2. Regatte RR

   . Biomedical applications of sodium MRI in vivo. J Magn Reson Imaging 2013;38:511–29 doi:10.1002/jmri.24168 pmid:23722972

   CrossRefPubMed
8. 8.↵
   1. Rooney WD,
   2. Springer CS Jr..

   The molecular environment of intracellular sodium: 23Na NMR relaxation. NMR Biomed 1991;4:227–45 doi:10.1002/nbm.1940040503 pmid:1751346

   CrossRefPubMed
9. 9.↵
   1. Tsang A,
   2. Stobbe RW,
   3. Beaulieu C

   . Triple-quantum-filtered sodium imaging of the human brain at 4.7 T. Magn Reson Med 2012;67:1633–43 doi:10.1002/mrm.23147 pmid:21956282

   CrossRefPubMed
10. 10.↵
    1. Liao Y,
    2. Lechea N,
    3. Magill AW, et al

    . Correlation of quantitative conductivity mapping and total tissue sodium concentration at 3T/4T. Magn Reson Med 2019;82:1518–26 doi:10.1002/mrm.27787 pmid:31095776

    CrossRefPubMed
11. 11.↵
    1. Qian Y,
    2. Zhao T,
    3. Zheng H, et al

    . High-resolution sodium imaging of human brain at 7 T. Magn Reson Med 2012;68:227–33 doi:10.1002/mrm.23225 pmid:22144258

    CrossRefPubMed
12. 12.↵
    1. Thulborn K,
    2. Lui E,
    3. Guntin J, et al

    . Quantitative sodium MRI of the human brain at 9.4 T provides assessment of tissue sodium concentration and cell volume fraction during normal aging. NMR Biomed 2016;29:137–43 doi:10.1002/nbm.3312 pmid:26058461

    CrossRefPubMed
13. 13.↵
    1. Harrington MG,
    2. Salomon RM,
    3. Pogoda JM, et al

    . Cerebrospinal fluid sodium rhythms. Cerebrospinal Fluid Res 2010;7:3 doi:10.1186/1743-8454-7-3 pmid:20205754

    CrossRefPubMed
14. 14.↵
    1. Bansal N,
    2. Germann MJ,
    3. Seshan V, et al

    . Thulium 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylene phosphonate) as a 23Na shift reagent for the in vivo rat liver. Biochemistry 1993;32:5638–43 doi:10.1021/bi00072a020 pmid:8504084

    CrossRefPubMed
15. 15.↵
    1. Winter PM,
    2. Bansal N

    . TmDOTP(5-) as a (23)Na shift reagent for the subcutaneously implanted 9L gliosarcoma in rats. Magn Reson Med 2001;45:436–42 doi:10.1002/1522-2594(200103)45:3<436::AID-MRM1057>3.0.CO;2-6 pmid:11241701

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Stobbe R,
    2. Beaulieu C

    . In vivo sodium magnetic resonance imaging of the human brain using soft inversion recovery fluid attenuation. Magn Reson Med 2005;54:1305–10 doi:10.1002/mrm.20696 pmid:16217782

    CrossRefPubMed
17. 17.↵
    1. Madelin G,
    2. Kline R,
    3. Walvick R, et al

    . A method for estimating intracellular sodium concentration and extracellular volume fraction in brain in vivo using sodium magnetic resonance imaging. Sci Rep 2014;4:4763 doi:10.1038/srep04763 pmid:24755879

    CrossRefPubMed
18. 18.↵
    1. Barrett T,
    2. Riemer F,
    3. McLean MA, et al

    . Quantification of total and intracellular sodium concentration in primary prostate cancer and adjacent normal prostate tissue with magnetic resonance imaging. Invest Radiol 2018;53:450–56 doi:10.1097/RLI.0000000000000470 pmid:29969108

    CrossRefPubMed
19. 19.↵
    1. Nunes Neto LP,
    2. Madelin G,
    3. Sood TP, et al

    . Quantitative sodium imaging and gliomas: a feasibility study. Neuroradiology 2018;60:795–802 doi:10.1007/s00234-018-2041-1 pmid:29862413

    CrossRefPubMed
20. 20.↵
    1. Hancu I,
    2. Boada FE,
    3. Shen GX

    . Three-dimensional triple-quantum-filtered (23)Na imaging of in vivo human brain. Magn Reson Med 1999;42:1146–54 doi:10.1002/(SICI)1522-2594(199912)42:6<1146::AID-MRM20>3.0.CO;2-S pmid:10571937

    CrossRefPubMed
21. 21.↵
    1. Fiege DP,
    2. Romanzetti S,
    3. Mirkes CC, et al

    . Simultaneous single-quantum and triple-quantum-filtered MRI of 23Na (SISTINA). Magn Reson Med 2013;69:1691–96 doi:10.1002/mrm.24417 pmid:22829484

    CrossRefPubMed
22. 22.↵
    1. Shymanskaya A,
    2. Worthoff WA,
    3. Stoffels G, et al

    . Comparison of [18F]Fluoroethyltyrosine PET and sodium MRI in cerebral gliomas: a pilot study. Mol Imaging Biol 2020;22:198–207 doi:10.1007/s11307-019-01349-y pmid:30989437

    CrossRefPubMed
23. 23.↵
    1. Shinar H,
    2. Navon G

    . NMR relaxation studies of intracellular Na+ in red blood cells. Biophys Chem 1984;20:275–83 doi:10.1016/0301-4622(84)80018-6 pmid:6509150

    CrossRefPubMed
24. 24.↵
    1. Burstein D,
    2. Fossel ET

    . Intracellular sodium and lithium NMR relaxation times in the perfused frog heart. Magn Reson Med 1987;4:261–73 doi:10.1002/mrm.1910040307 pmid:3494902

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Foy BD,
    2. Burstein D

    . Interstitial sodium nuclear magnetic resonance relaxation times in perfused hearts. Biophys J 1990;58:127–34 doi:10.1016/S0006-3495(90)82358-4 pmid:2383627

    CrossRefPubMed
26. 26.↵
    1. Jelicks LA,
    2. Paul PK,
    3. O’Byrne E, et al

    . Hydrogen-1, sodium-23, and carbon-13 MR spectroscopy of cartilage degradation in vitro. J Magn Reson Imaging 1993;3:565–68 doi:10.1002/jmri.1880030403 pmid:8347947

    CrossRefPubMed
27. 27.↵
    1. Burstein D,
    2. Springer CS Jr..

    Sodium MRI revisited. Magn Reson Med 2019;82:521–24 doi:10.1002/mrm.27738 pmid:30927278

    CrossRefPubMed
28. 28.↵
    1. Lachner S,
    2. Ruck L,
    3. Niesporek SC, et al

    . Comparison of optimized intensity correction methods for ²³Na MRI of the human brain using a 32-channel phased array coil at 7 Tesla. Z Med Phys 2020;30:104–15 doi:10.1016/j.zemedi.2019.10.004 pmid:31866116

    CrossRefPubMed
29. 29.↵
    1. Lei Y,
    2. Han H,
    3. Yuan F, et al

    . The brain interstitial system: anatomy, modeling, in vivo measurement, and applications. Prog Neurobiol 2017;157:230–46 doi:10.1016/j.pneurobio.2015.12.007 pmid:26837044

    CrossRefPubMed
30. 30.↵
    1. LaVerde G,
    2. Nemoto E,
    3. Jungreis CA, et al

    . Serial triple quantum sodium MRI during non-human primate focal brain ischemia. Magn Reson Med 2007;57:201–05 doi:10.1002/mrm.21087 pmid:17191243

    CrossRefPubMed
31. 31.↵
    1. Jelicks LA,
    2. Gupta RK

    . Multinuclear NMR studies of the Langendorff perfused rat heart. J Biol Chem 1989;264:15230–35 doi:10.1016/S0021-9258(19)84814-7 pmid:2768258

    Abstract/FREE Full Text
32. 32.↵
    1. Hutchison RB,
    2. Malhotra D,
    3. Hendrick RE, et al

    . Evaluation of the double-quantum filter for the measurement of intracellular sodium concentration. J Biol Chem 1990;265:15506–10 pmid:2394737

    Abstract/FREE Full Text
33. 33.↵
    1. Jelicks LA,
    2. Gupta RK

    . On the extracellular contribution to multiple quantum filtered ²³Na NMR of perfused rat heart. Magn Reson Med 1993;29:130–33 doi:10.1002/mrm.1910290124 pmid:8419734

    CrossRefPubMed
34. 34.↵
    1. Gaw N,
    2. Hawkins-Daarud A,
    3. Hu LS, et al

    . Integration of machine learning and mechanistic models accurately predicts variation in cell density of glioblastoma using multiparametric MRI. Sci Rep 2019;9:10063 doi:10.1038/s41598-019-46296-4 pmid:31296889

    CrossRefPubMed
35. 35.↵
    1. Lu A,
    2. Atkinson IC,
    3. Claiborne TC, et al

    . Quantitative sodium imaging with a flexible twisted projection pulse sequence. Magn Reson Med 2010;63:1583–93 doi:10.1002/mrm.22381 pmid:20512862

    CrossRefPubMed
36. 36.↵
    1. Shah NJ,
    2. Worthoff WA,
    3. Langen KJ

    . Imaging of sodium in the brain: a brief review. NMR Biomed 2016;29:162–74 doi:10.1002/nbm.3389 pmid:26451752

    CrossRefPubMed
37. 37.↵
    1. Zaric O,
    2. Juras V,
    3. Szomolanyi P, et al

    . Frontiers of sodium MRI revisited: from cartilage to brain imaging. J Magn Reson Imaging 2021;54:e27326–75 doi:10.1002/jmri.27326 pmid:32851736

    CrossRefPubMed
38. 38.↵
    1. Ridley B,
    2. Marchi A,
    3. Wirsich J, et al

    . Brain sodium MRI in human epilepsy: Disturbances of ionic homeostasis reflect the organization of pathological regions. Neuroimage 2017;157:173–83 doi:10.1016/j.neuroimage.2017.06.011 pmid:28602596

    CrossRefPubMed
39. 39.↵
    1. Thulborn KR,
    2. Lu A,
    3. Atkinson IC, et al

    . Residual tumor volume, cell volume fraction, and tumor cell kill during fractionated chemoradiation therapy of human glioblastoma using quantitative sodium MR imaging. Clin Cancer Res 2019;25:1226–32 doi:10.1158/1078-0432.CCR-18-2079 pmid:30487127

    Abstract/FREE Full Text
40. 40.↵
    1. Wiggins GC,
    2. Brown R,
    3. Lakshmanan K

    . High-performance radiofrequency coils for (23)Na MRI: brain and musculoskeletal applications. NMR Biomed 2016;29:96–106 doi:10.1002/nbm.3379 pmid:26404631

    CrossRefPubMed
41. 41.↵
    1. Wilcox M,
    2. Wright SM,
    3. McDougall M

    . A review of non-1H RF receive arrays in magnetic resonance imaging and spectroscopy. IEEE Open J Eng Med Biol 2020;1:290–300 doi:10.1109/OJEMB.2020.3030531

    CrossRef
42. 42.↵
    1. Lee RF,
    2. Giaquinto R,
    3. Constantinides C, et al

    . A broadband phased-array system for direct phosphorus and sodium metabolic MRI on a clinical scanner. Magn Reson Med 2000;43:269–77 doi:10.1002/(SICI)1522-2594(200002)43:2<269::AID-MRM14>3.0.CO;2-J pmid:10680691

    CrossRefPubMed
43. 43.↵
    1. Zamecnik J

    . The extracellular space and matrix of gliomas. Acta Neuropathol 2005;110:435–42 doi:10.1007/s00401-005-1078-5 pmid:16175354

    CrossRefPubMed
44. 44.↵
    1. Amara S,
    2. Tiriveedhi V

    . Inflammatory role of high salt level in tumor microenvironment (review). Int J Oncol 2017;50:1477–81 doi:10.3892/ijo.2017.3936 pmid:28350105

    CrossRefPubMed
45. 45.↵
    1. Leslie TK,
    2. James AD,
    3. Zaccagna F, et al

    . Sodium homeostasis in the tumour microenvironment. Biochim Biophys Acta Rev Cancer 2019;1872:188304 doi:10.1016/j.bbcan.2019.07.001 pmid:31348974

    CrossRefPubMed
46. 46.↵
    1. Ouwerkerk R,
    2. Bleich KB,
    3. Gillen JS, et al

    . Tissue sodium concentration in human brain tumors as measured with ²³Na MR imaging. Radiology 2003;227:529–37 doi:10.1148/radiol.2272020483 pmid:12663825

    CrossRefPubMedWeb of Science
47. 47.↵
    1. Bartha R,
    2. Megyesi JF,
    3. Watling CJ

    . Low-grade glioma: correlation of short echo time 1H-MR spectroscopy with ²³Na MR imaging. AJNR Am J Neuroradiol 2008;29:464–70 doi:10.3174/ajnr.A0854 pmid:18238848

    Abstract/FREE Full Text
48. 48.↵
    1. Nagel AM,
    2. Bock M,
    3. Hartmann C, et al

    . The potential of relaxation-weighted sodium magnetic resonance imaging as demonstrated on brain tumors. Invest Radio 2011;46:539–47 doi:10.1097/RLI.0b013e31821ae918 pmid:21577129

    CrossRefPubMed
49. 49.↵
    1. Thulborn KR,
    2. Davis D,
    3. Adams H, et al

    . Quantitative tissue sodium concentration mapping of the growth of focal cerebral tumors with sodium magnetic resonance imaging. Magn Reson Med 1999;41:351–59 doi:10.1002/(SICI)1522-2594(199902)41:2<351::AID-MRM20>3.0.CO;2-H pmid:10080284

    CrossRefPubMedWeb of Science
50. 50.↵
    1. Schepkin VD,
    2. Ross BD,
    3. Chenevert TL, et al

    . Sodium magnetic resonance imaging of chemotherapeutic response in a rat glioma. Magn Reson Med 2005;53:85–92 doi:10.1002/mrm.20332 pmid:15690506

    CrossRefPubMed
51. 51.↵
    1. Thulborn KR,
    2. Lu A,
    3. Atkinson IC, et al

    . Quantitative sodium MR imaging and sodium bioscales for the management of brain tumors. Neuroimaging Clin N Am 2009;19:615–24 doi:10.1016/j.nic.2009.09.001 pmid:19959008

    CrossRefPubMed
52. 52.↵
    1. Kuhn SA,
    2. Mueller U,
    3. Hanisch UK, et al

    . Glioblastoma cells express functional cell membrane receptors activated by daily used medical drugs. J Cancer Res Clin Oncol 2009;135:1729–45 doi:10.1007/s00432-009-0620-6 pmid:19543745

    CrossRefPubMed
53. 53.↵
    1. Cong D,
    2. Zhu W,
    3. Kuo JS, et al

    . Ion transporters in brain tumors. Curr Med Chem 2015;22:1171–81 doi:10.2174/0929867322666150114151946 pmid:25620102

    CrossRefPubMed
54. 54.↵
    1. McLean LA,
    2. Roscoe J,
    3. Jorgensen NK, et al

    . Malignant gliomas display altered pH regulation by NHE1 compared with nontransformed astrocytes. Am J Physiol Cell Physiol 2000;278:C676–88 doi:10.1152/ajpcell.2000.278.4.C676 pmid:10751317

    CrossRefPubMedWeb of Science
55. 55.↵
    1. Zhu W,
    2. Carney KE,
    3. Pigott VM, et al

    . Glioma-mediated microglial activation promotes glioma proliferation and migration: roles of Na+/H+ exchanger isoform 1. Carcinogenesis 2016;37:839–51 doi:10.1093/carcin/bgw068 pmid:27287871

    CrossRefPubMed
56. 56.↵
    1. Guan X,
    2. Hasan MN,
    3. Begum G, et al

    . Blockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy. Cell Death Dis 2018;9:1010 doi:10.1038/s41419-018-1062-3 pmid:30262908

    CrossRefPubMed
57. 57.↵
    1. Stock C,
    2. Pedersen SF

    . Roles of pH and the Na(+)/H(+) exchanger NHE1 in cancer: From cell biology and animal models to an emerging translational perspective? Semin Cancer Biol 2017;43:5–16 doi:10.1016/j.semcancer.2016.12.001 pmid:28007556

    CrossRefPubMed
58. 58.↵
    1. Cong D,
    2. Zhu W,
    3. Shi Y, et al

    . Upregulation of NHE1 protein expression enables glioblastoma cells to escape TMZ-mediated toxicity via increased H(+) extrusion, cell migration and survival. Carcinogenesis 2014;35:2014–24 doi:10.1093/carcin/bgu089 pmid:24717311

    CrossRefPubMed
59. 59.↵
    1. Biller A,
    2. Badde S,
    3. Nagel A, et al

    . Improved brain tumor classification by sodium MR imaging: prediction of IDH mutation status and tumor progression. AJNR Am J Neuroradiol 2016;37:66–73 doi:10.3174/ajnr.A4493 pmid:26494691

    Abstract/FREE Full Text
60. 60.↵
    1. Hashimoto T,
    2. Ikehira H,
    3. Fukuda H, et al

    . In vivo sodium-23 MRI in brain tumors: evaluation of preliminary clinical experience. Am J Physiol Imaging 1991;6:74–80

    PubMed
61. 61.↵
    1. Regnery S,
    2. Behl NG,
    3. Platt T, et al

    . Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patients. Neuroimage Clin 2020;28:102427 doi:10.1016/j.nicl.2020.102427 pmid:33002860

    CrossRefPubMed
62. 62.↵
    1. Xing Z,
    2. Yang X,
    3. She D, et al

    . Noninvasive assessment of IDH mutational status in World Health Organization grade II and III astrocytomas using DWI and DSC-PWI combined with conventional MR imaging. AJNR Am J Neuroradiol 2017;38:1138–44 doi:10.3174/ajnr.A5171 pmid:28450436

    Abstract/FREE Full Text
63. 63.↵
    1. Li Y,
    2. Shan X,
    3. Wu Z, et al

    . IDH1 mutation is associated with a higher preoperative seizure incidence in low-grade glioma: a systematic review and meta-analysis. Seizure 2018;55:76–82 doi:10.1016/j.seizure.2018.01.011 pmid:29414139

    CrossRefPubMed
64. 64.↵
    1. Ozer B,
    2. Bui Y,
    3. Markovic D, et al

    . NCMP-01: seizure control after initial presentation in IDH mutated glioma patients. Neuro Oncol 2017;19(Supple 6):vi135–36 doi:10.1093/neuonc/nox168.555

    CrossRef
65. 65.↵
    1. Laymon CM,
    2. Oborski MJ,
    3. Lee VK, et al

    . Combined imaging biomarkers for therapy evaluation in glioblastoma multiforme: correlating sodium MRI and F-18 FLT PET on a voxel-wise basis. Magn Reson Imaging 2012;30:1268–78 doi:10.1016/j.mri.2012.05.011 pmid:22819581

    CrossRefPubMed
66. 66.↵
    1. Haneder S,
    2. Giordano FA,
    3. Konstandin S, et al

    . ²³Na-MRI of recurrent glioblastoma multiforme after intraoperative radiotherapy: technical note. Neuroradiology 2015;57:321–26 doi:10.1007/s00234-014-1468-2 pmid:25428586

    CrossRefPubMed
67. 67.↵
    1. Schepkin VD

    . Sodium MRI of glioma in animal models at ultrahigh magnetic fields. NMR Biomed 2016;29:175–86 doi:10.1002/nbm.3347 pmid:26174529

    CrossRefPubMed
68. 68.↵
    1. Winter PM,
    2. Poptani H,
    3. Bansal N

    . Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered ²³Na and ³¹P nuclear magnetic resonance of the subcutaneously implanted 9L glioma. Cancer Res 2001;61:2002–07 pmid:11280759

    Abstract/FREE Full Text
69. 69.↵
    1. Dijkstra K,
    2. Hofmeijer J,
    3. van Gils SA, et al

    . A biophysical model for cytotoxic cell swelling. J Neurosci 2016;36:11881–90 doi:10.1523/JNEUROSCI.1934-16.2016 pmid:27881775

    Abstract/FREE Full Text
70. 70.↵
    1. Dani KA,
    2. Warach S

    . Metabolic imaging of ischemic stroke: the present and future. AJNR Am J Neuroradiol 2014;35:S37–43 doi:10.3174/ajnr.A3789 pmid:24722308

    Abstract/FREE Full Text
71. 71.↵
    1. Thulborn KR,
    2. Gindin TS,
    3. Davis D, et al

    . Comprehensive MR imaging protocol for stroke management: tissue sodium concentration as a measure of tissue viability in nonhuman primate studies and in clinical studies. Radiology 1999;213:156–66 doi:10.1148/radiology.213.1.r99se15156 pmid:10540656

    CrossRefPubMedWeb of Science
72. 72.↵
    1. Wang Y,
    2. Hu W,
    3. Perez-Trepichio AD, et al

    . Brain tissue sodium is a ticking clock telling time after arterial occlusion in rat focal cerebral ischemia. Stroke 2000;31:1386–91; discussion 92 doi:10.1161/01.STR.31.6.1386 pmid:10835461

    Abstract/FREE Full Text
73. 73.↵
    1. Hussain MS,
    2. Stobbe RW,
    3. Bhagat YA, et al

    . Sodium imaging intensity increases with time after human ischemic stroke. Ann Neurol 2009;66:55–62 doi:10.1002/ana.21648 pmid:19670436

    CrossRefPubMed
74. 74.↵
    1. Neumaier-Probst E,
    2. Konstandin S,
    3. Ssozi J, et al

    . A double-tuned (1) H/(23) Na resonator allows (1) H-guided (23)Na-MRI in ischemic stroke patients in one session. Int J Stroke 2015;10:56–61 doi:10.1111/ijs.12547 pmid:26121064

    CrossRefPubMed
75. 75.↵
    1. Shen JM,
    2. Xia XW,
    3. Kang WG, et al

    . The use of MRI apparent diffusion coefficient (ADC) in monitoring the development of brain infarction. BMC Med Imaging 2011;11:2 doi:10.1186/1471-2342-11-2 pmid:21211049

    CrossRefPubMed
76. 76.↵
    1. Tsang A,
    2. Stobbe RW,
    3. Asdaghi N, et al

    . Relationship between sodium intensity and perfusion deficits in acute ischemic stroke. J Magn Reson Imaging 2011;33:41–47 doi:10.1002/jmri.22299 pmid:21182119

    CrossRefPubMed
77. 77.↵
    1. Cressman JR Jr.,
    2. Ullah G,
    3. Ziburkus J, et al

    . The influence of sodium and potassium dynamics on excitability, seizures, and the stability of persistent states, I: single neuron dynamics. J Comput Neurosci 2009;26:159–70 doi:10.1007/s10827-008-0132-4 pmid:19169801

    CrossRefPubMedWeb of Science
78. 78.↵
    1. Kunz WS,
    2. Kudin AP,
    3. Vielhaber S, et al

    . Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann Neurol 2000;48:766–73 pmid:11079540

    CrossRefPubMedWeb of Science
79. 79.↵
    1. Folbergrová J,
    2. Kunz WS

    . Mitochondrial dysfunction in epilepsy. Mitochondrion 2012;12:35–40 doi:10.1016/j.mito.2011.04.004 pmid:21530687

    CrossRefPubMedWeb of Science
80. 80.↵
    1. Dietzel I,
    2. Heinemann U,
    3. Hofmeier G, et al

    . Stimulus-induced changes in extracellular Na+ and Cl- concentration in relation to changes in the size of the extracellular space. Exp Brain Res 1982;46:73–84 doi:10.1007/BF00238100 pmid:6279427

    CrossRefPubMedWeb of Science
81. 81.↵
    1. Antonio LL,
    2. Anderson ML,
    3. Angamo EA, et al

    . In vitro seizure-like events and changes in ionic concentration. J Neurosci Methods 2016;260:33–44 doi:10.1016/j.jneumeth.2015.08.014

    CrossRefPubMed
82. 82.↵
    1. Patel DC,
    2. Tewari BP,
    3. Chaunsali L, et al

    . Neuron-glia interactions in the pathophysiology of epilepsy. Nat Rev Neurosci 2019;20:282–97 doi:10.1038/s41583-019-0126-4 pmid:30792501

    CrossRefPubMed
83. 83.↵
    1. Wang Y,
    2. Majors A,
    3. Najm I, et al

    . Postictal alteration of sodium content and apparent diffusion coefficient in epileptic rat brain induced by kainic acid. Epilepsia 1996;37:1000–06 doi:10.1111/j.1528-1157.1996.tb00539.x pmid:8822700

    CrossRefPubMedWeb of Science